Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Kangrentang Pharmaceutical is a leading Chinese pharmaceutical company specializing in the research, development, and manufacturing of Traditional Chinese Medicine (TCM) formula granules. Founded in 2003 and now a key subsidiary of China Traditional Chinese Medicine Holdings (China TCM), the company is a pioneer in the modernization of herbal medicine through its proprietary Full-component technology. This platform ensures that the resulting granules maintain the same chemical profile and therapeutic efficacy as traditional decoctions. Kangrentang produces over 600 varieties of single-herb granules, serving a vast network of medical institutions across China. The company operates state-of-the-art GMP-certified facilities and is recognized as one of the original pilot enterprises approved by the Chinese government for granule production. Its commitment to quality and standardization has made it a dominant player in the Chinese TCM market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Kang-Ren-Tang Pharmaceutical.